Life sciences and IT investment firm Polaris Venture Partners has raised $233 million of an anticipated $400 million fund, according to a filing with the Securities and Exchange Commission.
The $400 million goal appears to represent scaled-down expectations for the venture luminary, which had previously targeted $500 million for its sixth fund, VentureWire reported. Polaris’ fifth fund closed at $1 billion in 2006.
Polaris’ portfolio companies include PartsSource Inc., an Aurora, Ohio-based supplier of replacement parts for hospital equipment, and Apnex Medical Inc., a St. Paul, Minn.-based sleep-apnea device firm. Other portfolio companies include Ironwood Pharmaceuticals, BridgePoint Medical and Asthmatx.
Changes in Nurse Staffing Answer Clinician Demands
The ongoing nursing shortage facilitates high turnover rates since nurses know they won’t have difficulties finding new jobs. In order to retain and attract staff, it’s in a facility’s best interest to understand what nurses want.
Polaris’ $50 million investment in PartsSource in 2008 represented the year’s largest funding of any healthcare firm in Northeast Ohio.
Polaris’ smaller-than-anticipated fundraise may be a signal that smaller, targeted funds are the way forward for the struggling venture capital industry. Ten-year venture capital returns have fallen in recent years, as the once-lucrative IPO market has slowed and technology startups no longer need as much capital as they once did to get rolling. That’s led to much hand-wringing in recent years about the venture model being “broken.” Polaris’ latest fund could be a sign that the critics were right.